Diversified Portfolios, Inc. Bristol Myers Squibb CO Transaction History

Diversified Portfolios, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$65.71 - $74.53 $91,993 - $104,342	-1,400 Reduced 31.78%	3,005 $208,000
Q4 2022 Jan 24, 2023	SELL	$68.48 - $81.09 $259,265 - $307,006	-3,786 Reduced 46.22%	4,405 $0
Q3 2022 Nov 07, 2022	SELL	$0.13 - $76.84 $83 - $49,177	-640 Reduced 7.25%	8,191 $582,000
Q2 2022 Aug 09, 2022	SELL	$72.62 - $79.98 $134,564 - $148,202	-1,853 Reduced 17.34%	8,831 $680,000
Q1 2022 May 12, 2022	BUY	$61.48 - $73.72 $49,184 - $58,976	800 Added 8.09%	10,684 $780,000
Q4 2021 Jan 31, 2022	BUY	$53.63 - $62.52 $96,534 - $112,536	1,800 Added 22.27%	9,884 $616,000
Q2 2021 Aug 03, 2021	BUY	$61.91 - $67.42 $500,480 - $545,023	8,084 New	8,084 $540,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Diversified Portfolios, Inc., based on Form 13F filings with the SEC.

Stay updated on Diversified Portfolios, Inc. with notifications on news.